Stock Insight

The Ozempic moment for SaaS

The Ozempic moment for SaaS

Written by Ron Shamgar The Ozempic moment for SaaS refers to a pivotal disruption scenario where a transformative technology threatens to erode or fundamentally reshape an established market leader's core business model, much like the hype around Ozempic (and other...

The Reawakening of Small and Mid Caps

The Reawakening of Small and Mid Caps

Written by Ron Shamgar After two years of relative underperformance, Australian small and mid caps are finally showing signs of life. With inflation easing, rate cuts now on the horizon, and investor sentiment gradually shifting back toward growth, we believe the next...

The Takeover Tension: Why ASX Small Caps Are Back in Vogue

The Takeover Tension: Why ASX Small Caps Are Back in Vogue

Written by Ron Shamgar After a year dominated by global mega-cap tech and AI headlines, a different story is quietly unfolding on the ASX: the resurgence of small caps, particularly those in the crosshairs of private equity and strategic acquirers. With interest rates...

Sign Up to Our Weekly Stock Insights

Categories

Popular Topics